Richard Hoyt
Voorzitter bij ZYUS LIFE SCIENCES CORPORATION
Vermogen: 117 687 $ op 30-04-2024
Actieve functies van Richard Hoyt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZYUS LIFE SCIENCES CORPORATION | Voorzitter | 01-09-2020 | - |
XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | - | - |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Voorzitter | - | - |
Directeur/Bestuurslid | - | - | |
Ozark Transaction Advisors LLC | Corporate Officer/Principal | - | - |
Loopbaan van Richard Hoyt
Eerdere bekende functies van Richard Hoyt
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CANNIMED THERAPEUTICS INC | Directeur/Bestuurslid | 01-01-2012 | 15-03-2018 |
Independent Dir/Board Member | 01-01-2012 | 15-03-2018 | |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - | - |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Directeur/Bestuurslid | - | - |
MALLINCKRODT PLC | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigde Staten | 5 |
Canada | 3 |
Ierland | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Chairman | 2 |
Sectoraal
Health Technology | 6 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MALLINCKRODT PLC | Health Technology |
XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
CanniMed Therapeutics, Inc.
CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
ZYUS Life Sciences Corp. | |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Ozark Transaction Advisors LLC |
- Beurs
- Insiders
- Richard Hoyt
- Ervaring